Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biomedica (OXB) Regulatory News

Date Source Headline
20th May 2021 11:42 am RNS PDMR Dealings
18th May 2021 7:00 am RNS Oxford Biomedica upgrades financial guidance
10th May 2021 10:54 am RNS Holding(s) in Company
4th May 2021 10:29 am RNS Total Voting Rights
4th May 2021 10:27 am RNS Holdings in Company
27th Apr 2021 2:40 pm RNS 2020 Annual report and Accounts & AGM Notification
26th Apr 2021 12:32 pm RNS Holding(s) in Company
15th Apr 2021 7:00 am RNS Full year results
6th Apr 2021 7:00 am RNS OXB signs Agreement with Boehringer Ingelheim
1st Apr 2021 11:04 am RNS Total Voting Rights
30th Mar 2021 10:22 am RNS Holding(s) in Company
19th Mar 2021 7:01 am RNS Update on Sanofi Collaboration & License Agreement
15th Mar 2021 10:03 am RNS Notice of Preliminary Results
1st Mar 2021 9:36 am RNS Total Voting Rights
26th Feb 2021 10:46 am RNS PDMR Dealings / Market Share sale
5th Feb 2021 1:22 pm RNS Holdings in Company
3rd Feb 2021 7:00 am RNS Board Changes
1st Feb 2021 9:47 am RNS Total Voting Rights
4th Jan 2021 2:09 pm RNS Block Listing Return
4th Jan 2021 1:41 pm RNS Total Voting Rights
30th Dec 2020 9:03 am RNS OXB notes AZ vaccine has been authorised in the UK
1st Dec 2020 12:17 pm RNS Director Dealings
1st Dec 2020 9:02 am RNS Total Voting Rights
23rd Nov 2020 8:47 am RNS OXB notes AZD1222 met primary efficacy endpoint
23rd Nov 2020 7:00 am RNS Non-Executive Director Appointment
9th Nov 2020 7:00 am RNS OXB and PhoreMost enter gene therapy collaboration
2nd Nov 2020 9:02 am RNS Total Voting Rights
30th Oct 2020 7:00 am RNS Axovant update on AXO-Lenti-PD and virtual R&D day
23rd Oct 2020 10:27 am RNS Director Purchase
12th Oct 2020 5:38 pm RNS Holding(s) in Company
6th Oct 2020 12:46 pm RNS Axovant update on 2nd cohort of SUNRISE-PD trial
6th Oct 2020 7:00 am RNS OXB receives approval for fourth suite in Oxbox
5th Oct 2020 10:59 am EQS Edison Investment Research Limited: Oxford Biomedica (OXB): Vector innovation key to cell and gene evolution
2nd Oct 2020 11:52 am RNS Total Voting Rights
29th Sep 2020 3:51 pm RNS Director Dealings
24th Sep 2020 9:36 am RNS Director/PDMR Shareholding
22nd Sep 2020 12:54 pm RNS Director/PDMR Shareholding
17th Sep 2020 7:00 am RNS Interim Results
1st Sep 2020 9:33 am RNS Total Voting Rights
1st Sep 2020 7:00 am RNS Master Supply and Development Agreement with AZ
FTSE 100 Latest
Value8,774.65
Change-17.15